Upregulation of neuronal PGC-1? ameliorates cognitive impairment induced by chronic cerebral hypoperfusion.
Ontology highlight
ABSTRACT: Rationale: Mitochondrial dysfunction and oxidative stress occur in vascular dementia (VaD), but the specific molecular mechanism regulating these events remains unclear. Peroxisome proliferator-activated receptor-? co-activator-1? (PGC-1?) is a master regulator for mitochondrial function. This study aims to investigate whether PGC-1? is involved in the pathophysiology of VaD. Methods: We firstly generated PGC-1? f/f Eno2-Cre mice to induce neuron-specific overexpression of PGC-1? by crossbreeding PGC-1? f/f mice with Eno2-cre mice. Then, the mice were subjected to bilateral common carotid artery stenosis to induce chronic cerebral hypoperfusion. Neurological function and hippocampal PGC-1? expression was evaluated. Next, RNA-Seq analysis and Seahorse assay were performed on the hippocampal neurons. In addition, mitochondrial antioxidants, uncoupling proteins, ROS production and the activation of glial cells were also measured. Results: Our results showed that hippocampal PGC-1? expression is down-regulated in the mouse VaD model induced by chronic cerebral hypoperfusion. In contrast, neuronal PGC-1? overexpression significantly ameliorated cognitive deficits. RNA-Seq analysis indicated that PGC-1? improved energy metabolism of neurons under hypoxic condition, and Seahorse assay confirmed that PGC-1? increases the metabolic activity of neurons. Further study demonstrated that PGC-1? boosted the expressions of mitochondrial antioxidants and uncoupling proteins (UCPs), including SOD2, Prx3, GPx1, UCP2, UCP4 and UCP5, which in turn reduced reactive oxygen species (ROS) production. Moreover, the activation of microglia and astrocytes was also found to decrease in the hippocampus. All of these changes greatly contributed to protect hippocampal neurons against ischemic insults. Conclusions: PGC-1? could suppress the excessive ROS and neuroinflammation in the hippocampus, opening up a potential therapeutic target for cognitive impairment.
SUBMITTER: Han B
PROVIDER: S-EPMC7052889 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA